 Thirty GAVI countries have expressed interest in participating by 2010.PneumoADIP aims to save 5.4 million children by 2030.A pilot Advance Market Commitment (AMC) to develop a vaccine against pneumococcus was launched by GAVI in June 2009 as a strategy to address two of the major policy challenges to vaccine introduction